Company intelligence / Profile preview

Advanced Biomed Inc.

New York, New York, United Statesadvanbiomed.com ↗

Ownership: Private
Employees: ~40
Development stage: Preclinical

Overview

Advanced Biomed develops microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment. The company has completed development of three equipment systems (A+Pre, AC-1000, A+SCDrop) and three microfluidic biochips (A+Pre Chip, AC-1000 CTC enrichment chip, A+CellScan chip) that are ready for mass production. Their A+LCGuard product for lung cancer screening has completed a prospective study and is ready for commercialization.

Therapeutic areas: Oncology
Modalities: Microfluidic biochip technologiesLiquid biopsies
Industry: Pathology

Drug pipeline

3 assets

A + Pre

Commercial

Indications: Cancer screening

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Advanced Biomed Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Biomed Inc..

Explore the full profile